Cancer

Research Focus

The number of cancer cases worldwide is expected to increase to ~24 million by 2035. While there is a wide diversity of cancer types and characterizations, all cancers involve several hallmarks, including sustained proliferative signaling, evading growth suppressors, and resistance to cell death.
NIBN’s Cancer research group focuses on multi-disciplinary themes towards understanding the molecular basis of these diseases to generate better models, improve diagnoses, and find, design, or develop new anti-cancer therapeutics.